What is Regenxbio's debt-to-equity?

Regenxbio (RGNX) reported debt-to-equity of 3.4× in Q1 2026.

How has Regenxbio's debt-to-equity changed year-over-year?

Regenxbio's debt-to-equity increased by 1057.6% year-over-year, from 0.3× to 3.4×.

What is the long-term trend for Regenxbio's debt-to-equity?

Over 5 years (2020 to 2025), Regenxbio's debt-to-equity has grown at a 30.1% compound annual growth rate (CAGR), from 0.2× to 0.7×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

Regenxbio RGNX Debt-to-equity

Debt-to-equity at other companies

Regeneron PharmaceuticalsREGN

0.1×0.0×

Sarepta Therapeutics, Inc.SRPT

0.1×0.0×

BiogenBIIB

0.4×+0.1×

BioMarin PharmaceuticalsBMRN

0.2×+0.1×

EyePoint, Inc. EYPT

0.1×0.0×

Ultragenyx PharmaceuticalRARE

3.7×—

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Current ratio2.6×-0.3×

Where this comes from

Calculated from Regenxbio’s reported figures.

total debt/total stockholders equity=3.4×

Based on the most recent quarter.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's debt-to-equity?: Regenxbio (RGNX) reported debt-to-equity of 3.4× in Q1 2026.
How has Regenxbio's debt-to-equity changed year-over-year?: Regenxbio's debt-to-equity increased by 1057.6% year-over-year, from 0.3× to 3.4×.
What is the long-term trend for Regenxbio's debt-to-equity?: Over 5 years (2020 to 2025), Regenxbio's debt-to-equity has grown at a 30.1% compound annual growth rate (CAGR), from 0.2× to 0.7×.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.